Loci controlling lymphocyte production of interferon γ after alloantigen stimulation in vitro and their co-localization with genes controlling lymphocyte infiltration of tumors and tumor susceptibility

Cancer Immunology, Immunotherapy

Volumn 59, Issue 2, 2010, Pages 203-213

  Lipoldová, Marie ^a   Havelková, Helena ^a   Badalová, Jana ^a,b   Vojtíšková, Jarmila ^a   Quan, Lei ^c   Krulová, Magdaléna ^a   Sohrabi, Yahya ^a   Stassen, Alphons P ^d   Demant, Peter ^c  

^a INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

^b INSTITUTE FOR THE CARE OF MOTHER AND CHILD   (Czech Republic)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Gene mapping; Genetic control of interferon production; Lymphocyte infiltration of tumors; Tumor susceptibility

Indexed keywords

ALLOANTIGEN; CONCANAVALIN A; GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CANCER SUSCEPTIBILITY; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE CLUSTER; GENE CONTROL; GENE LOCATION; GENE LOCUS; GENETIC SUSCEPTIBILITY; GENOTYPE; IMMUNOSTIMULATION; IN VITRO STUDY; IRRADIATION; LYMPHOCYTIC INFILTRATION; LYMPHOCYTOPOIESIS; MALE; MICROSATELLITE MARKER; MOLECULAR PHYLOGENY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TUMOR GROWTH;

ANIMALS; CHROMOSOME MAPPING; FEMALE; GENETIC LOCI; INTERFERON-GAMMA; ISOANTIGENS; LYMPHOCYTE CULTURE TEST, MIXED; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, MUTANT STRAINS;

EID: 71849099677     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-009-0739-y     Document Type: Article

References (63)

1. KE de Visser A Eichten LM Coussens 2006 Paradoxical roles of the immune system during cancer development Nat Rev Cancer 6 24 37 10.1038/nrc1782 16397525 (Pubitemid 43053650)
2. G Klein S Imreh ER Zabarovsky 2007 Why do we not all die of cancer at an early age? Adv Cancer Res 98 1 16 10.1016/S0065-230X(06)98001-4 17433906 (Pubitemid 46551248)
3. MJ Smyth GP Dunn RD Schreiber 2006 Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity Adv Immunol 90 1 50 10.1016/S0065-2776(06)90001-7 16730260 (Pubitemid 43765795)
4. G Willimsky T Blankenstein 2007 The adaptive immune response to sporadic cancer Immunol Rev 220 102 112 10.1111/j.1600-065X.2007.00578.x 17979842 (Pubitemid 350045578)
5. J Galon A Costes F Sanchez-Cabo A Kirilovsky B Mlecnik C Lagorce-Pages M Tosolini M Camus A Berger P Wind F Zinzindohoue P Bruneval PH Cugnenc Z Trajanoski WH Fridman F Pages 2006 Type, density, and location of immune cells within human colorectal tumors predict clinical outcome Science 313 1960 1964 10.1126/science.1129139 17008531 (Pubitemid 44498003)
6. JD Bui R Uppaluri CS Hsieh RD Schreiber 2006 Comparative analysis of regulatory and effector T cells in progressively growing versus rejecting tumors of similar origins Cancer Res 66 7301 7309 10.1158/0008-5472.CAN-06-0556 16849580 (Pubitemid 44197712)
7. Q Chen WC Wang SS Evans 2003 Tumor microvasculature as a barrier to antitumor immunity Cancer Immunol Immunother 52 670 679 10.1007/s00262-003-0425- 4 12920482 (Pubitemid 37363637)
8. H Horlings P Demant 2005 Lung tumor location and lymphocyte infiltration in mice are genetically determined Exp Lung Res 31 513 525 16019985
9. N Kakarlapudi JH Vernooy L Quan RJ Fijneman P Demant 2008 Control of lymphocyte infiltration of lung tumors in mice by host's genes: mapping of four Lynf (lymphocyte infiltration) loci Cancer Immunol Immunother 57 217 225 10.1007/s00262-007-0367-3 17703301 (Pubitemid 350159923)
10. RJ Fijneman M Vos J Berkhof P Demant G Kraal 2004 Genetic analysis of macrophage characteristics as a tool to identify tumor susceptibility genes: mapping of three macrophage-associated risk inflammatory factors, marif1, marif2, and marif3 Cancer Res 64 3458 3464 10.1158/0008-5472.CAN-03-3767 15150098 (Pubitemid 38657918)
11. M Lipoldová H Havelková J Badalová P Demant 2005 Novel loci controlling lymphocyte proliferative response to cytokines and their clustering with loci controlling autoimmune reactions, macrophage function and lung tumor susceptibility Int J Cancer 114 394 399 10.1002/ijc.20731 15551356 (Pubitemid 40279959)
12. WF Bodmer EA Jones CJ Barnstable JG Bodmer 1978 Genetics HLA: the major human histocompatibility system Proc R Soc Lond B Biol Sci 202 93 116 10.1098/rspb.1978.0059 27817
13. BT Huber 1992 Mls genes and self-superantigens Trends Genet 8 399 402 1332231
14. X Feng KM Hui HM Younes AG Brickner 2008 Targeting minor histocompatibility antigens in graft versus tumor or graft versus leukemia responses Trends Immunol 29 624 632 10.1016/j.it.2008.09.004 18952501
15. M Rychlikova P Demant P Ivanyi 1973 The mixed lymphocyte reaction in H-2K, H-2D, and non-H-2 incompatibility Biomedicine 18 401 407 4270937
16. V Holán H Havelková M Krulová P Demant M Lipoldová 2000 A novel alloreactivity-controlling locus, Alan1, mapped to mouse chromosome 17 Immunogenetics 51 755 757 10.1007/s002510000197 10941849 (Pubitemid 30447213)
17. H Havelková J Badalová P Demant M Lipoldová 2000 A new type of genetic regulation of allogeneic response. A novel locus on mouse chromosome 4, Alan2 controls MLC reactivity to three different alloantigens: C57BL/10, BALB/c and CBA Genes Immun 1 483 487 10.1038/sj.gene.6363711 11197689
18. P Demant AA Hart 1986 Recombinant congenic strains-a new tool for analyzing genetic traits determined by more than one gene Immunogenetics 24 416 422 10.1007/BF00377961 3793154 (Pubitemid 17040155)
19. V Holan M Lipoldová P Demant 1996 Identical genetic control of MLC reactivity to different MHC incompatibilities, independent of production of and response to IL-2 Immunogenetics 44 27 35 10.1007/BF02602654 8613140
20. H Havelková V Holan L Karnik M Lipoldová 2006 Mouse model for analysis of non-MHC genes that influence allogeneic response: recombinant congenic strains of OcB/Dem series that carry identical H2 locus Central European Journal of Biology 1 16 28 10.2478/s11535-006-0002-x (Pubitemid 44325703)
21. JR Schoenborn CB Wilson 2007 Regulation of interferon-gamma during innate and adaptive immune responses Adv Immunol 96 41 101 10.1016/S0065-2776(07) 96002-2 17981204 (Pubitemid 350018717)
22. SE Street JA Trapani D MacGregor MJ Smyth 2002 Suppression of lymphoma and epithelial malignancies effected by interferon gamma J Exp Med 196 129 134 10.1084/jem.20020063 12093877 (Pubitemid 34747318)
23. T Enzler S Gillessen JP Manis D Ferguson J Fleming FW Alt M Mihm G Dranoff 2003 Deficiencies of GM-CSF and interferon gamma link inflammation and cancer J Exp Med 197 1213 1219 10.1084/jem.20021258 12732663 (Pubitemid 36570077)
24. Z Qin HJ Kim J Hemme T Blankenstein 2002 Inhibition of methylcholanthrene-induced carcinogenesis by an interferon gamma receptor-dependent foreign body reaction J Exp Med 195 1479 1490 10.1084/jem.20011887 12045246 (Pubitemid 34602825)
25. T Blankenstein 2005 The role of tumor stroma in the interaction between tumor and immune system Curr Opin Immunol 17 180 186 10.1016/j.coi.2005.01.008 15766679 (Pubitemid 40343106)
26. Klein J (1989) Immunologically important loci. In: Lyon M, Searle A (eds) Genetic variants and strains of the laboratory mouse. Oxford University Press, Oxford
27. AP Stassen PC Groot JT Eppig P Demant 1996 Genetic composition of the recombinant congenic strains Mamm Genome 7 55 58 10.1007/s003359900013 8903730
28. M Lipoldová M Kosarová A Zajicová V Holán AA Hart M Krulová P Demant 1995 Separation of multiple genes controlling the T-cell proliferative response to IL-2 and anti-CD3 using recombinant congenic strains Immunogenetics 41 301 311 10.1007/BF00172155 7721352
29. W Dietrich H Katz SE Lincoln HS Shin J Friedman NC Dracopoli ES Lander 1992 A genetic map of the mouse suitable for typing intraspecific crosses Genetics 131 423 447 1353738
30. N Tripodis AA Hart RJ Fijneman P Demant 2001 Complexity of lung cancer modifiers: mapping of thirty genes and twenty-five interactions in half of the mouse genome J Natl Cancer Inst 93 1484 1491 10.1093/jnci/93.19.1484 11584065
31. E Lander L Kruglyak 1995 Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results Nat Genet 11 241 247 10.1038/ng1195-241 7581446
32. M Kosarová H Havelková M Krulová P Demant M Lipoldová 1999 The production of two Th2 cytokines, interleukin-4 and interleukin-10, is controlled independently by locus Cypr1 and by loci Cypr2 and Cypr3, respectively Immunogenetics 49 134 141 10.1007/s002510050472 9887350 (Pubitemid 29037601)
33. PC Groot CJ Moen W Dietrich JP Stoye ES Lander P Demant 1992 The recombinant congenic strains for analysis of multigenic traits: genetic composition FASEB J 6 2826 2835 1634045
34. P Demant 2003 Cancer susceptibility in the mouse: genetics, biology and implications for human cancer Nat Rev Genet 4 721 734 10.1038/nrg1157 12951573 (Pubitemid 37046139)
35. J Cui T Shin T Kawano H Sato E Kondo I Toura Y Kaneko H Koseki M Kanno M Taniguchi 1997 Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors Science 278 1623 1626 10.1126/science.278.5343.1623 9374462 (Pubitemid 27516281)
36. DK Blanchard JY Djeu TW Klein H Friedman WE Stewart 2nd 1986 Interferon-gamma induction by lipopolysaccharide: dependence on interleukin 2 and macrophages J Immunol 136 963 970 2867114
37. Y Murata T Ohteki S Koyasu J Hamuro 2002 IFN-gamma and pro-inflammatory cytokine production by antigen-presenting cells is dictated by intracellular thiol redox status regulated by oxygen tension Eur J Immunol 32 2866 2873 10.1002/1521-4141(2002010)32:10<2866::AID-IMMU2866>3.0.CO;2-V 12355439 (Pubitemid 35238179)
38. J Vilcek D Henriksen-Destefano D Siegel A Klion RJ Robb J Le 1985 Regulation of IFN-gamma induction in human peripheral blood cells by exogenous and endogenously produced interleukin 2 J Immunol 135 1851 1856 3926889
39. AJ Sadler BR Williams 2008 Interferon-inducible antiviral effectors Nat Rev Immunol 8 559 568 10.1038/nri2314 18575461 (Pubitemid 351913674)
40. KJ Kim G Chaouat WM Leiserson J King E De Maeyer 1983 Characterization of T-cell-soluble factors modulating the expression of Ia and H-2 antigens on BALB/c B lymphoma cell lines Cell Immunol 76 253 267 10.1016/0008-8749(83)90368- 4 6404559
41. DH Kaplan V Shankaran AS Dighe E Stockert M Aguet LJ Old RD Schreiber 1998 Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice Proc Natl Acad Sci USA 95 7556 7561 10.1073/pnas.95.13. 7556 9636188 (Pubitemid 28293291)
42. H Nagase JH Mao A Balmain 2003 Allele-specific Hras mutations and genetic alterations at tumor susceptibility loci in skin carcinomas from interspecific hybrid mice Cancer Res 63 4849 4853 12941805
43. MF Festing L Lin TR Devereux F Gao A Yang CH Anna CM White AM Malkinson M You 1998 At least four loci and gender are associated with susceptibility to the chemical induction of lung adenomas in A/J × BALB/c mice Genomics 53 129 136 10.1006/geno.1998.5450 9790761 (Pubitemid 28496602)
44. H Wang D Teske A Tess R Kohlhepp Y Choi C Kendziorski AR Moser 2007 Identification of novel modifier loci of Apc Min affecting mammary tumor development Cancer Res 67 11226 11233 10.1158/0008-5472.CAN-07-2487 18056448 (Pubitemid 350248548)
45. GH Lee JM Bugni M Obata H Nishimori K Ogawa NR Drinkwater 1997 Genetic dissection of susceptibility to murine ovarian teratomas that originate from parthenogenetic oocytes Cancer Res 57 590 593 9044831
46. N Tripodis P Demant 2003 Genetic analysis of three-dimensional shape of mouse lung tumors reveals eight lung tumor shape-determining (Ltsd) loci that are associated with tumor heterogeneity and symmetry Cancer Res 67 125 131
47. GH Lee K Ogawa H Nishimori NR Drinkwater 1995 Most liver epithelial cell lines from C3B6F1 mice exhibit parentally-biased loss of heterozygosity at the Lci (Liver cell immortalization) locus on chromosome 4 Oncogene 11 2281 2287 8570178 (Pubitemid 26008404)
48. M Cool F Depault P Jolicoeur 2006 Fine allelotyping of Erbb2-induced mammary tumors in mice reveals multiple discontinuous candidate regions of tumor-suppressor loci Genes Chromosomes Cancer 45 191 202 10.1002/gcc.20276 16258954 (Pubitemid 43191026)
49. D Meruelo M Offer N Flieger 1981 Genetics of susceptibility for radiation-induced leukemia. Mapping of genes involved to chromosomes 1, 2, and 4, and implications for a viral etiology in the disease J Exp Med 154 1201 1211 10.1084/jem.154.4.1201 6270228 (Pubitemid 11023108)
50. J Santos M Herranz I Perez de Castro A Pellicer J Fernandez-Piqueras 1998 A new candidate site for a tumor suppressor gene involved in mouse thymic lymphomagenesis is located on the distal part of chromosome 4 Oncogene 17 925 929 10.1038/sj.onc.1202009 9780010
51. XX Zhu K Kozarsky JR Strahler C Eckerskorn F Lottspeich R Melhem J Lowe DA Fox SM Hanash GF Atweh 1989 Molecular cloning of a novel human leukemia-associated gene. Evidence of conservation in animal species J Biol Chem 264 14556 14560 2760073
52. M Cool P Jolicoeur 1999 Elevated frequency of loss of heterozygosity in mammary tumors arising in mouse mammary tumor virus/neu transgenic mice Cancer Res 59 2438 2444 10344755
53. RJ Fijneman RC Jansen MA van der Valk P Demant 1998 High frequency of interactions between lung cancer susceptibility genes in the mouse: mapping of Sluc5 to Sluc14 Cancer Res 58 4794 4798 9809979
54. RJ Fijneman P Demant 1995 A gene for susceptibility to small intestinal cancer, ssic1, maps to the distal part of mouse chromosome 4 Cancer Res 55 3179 3182 7606739
55. Y Matsuda T Ozaki H Enomoto T Saito S Sakiyama 1996 Chromosome mapping of the mouse and rat homologs of the human DAN gene, D1S1733E Mamm Genome 7 709 710 10.1007/s003359900216 8703135 (Pubitemid 126443519)
56. BA Mock MM Krall JK Dosik 1993 Genetic mapping of tumor susceptibility genes involved in mouse plasmacytomagenesis Proc Natl Acad Sci USA 90 9499 9503 10.1073/pnas.90.20.9499 8105477 (Pubitemid 23315812)
57. AM Dorward KL Shultz LG Horton R Li GA Churchill WG Beamer 2005 Distal Chr 4 harbors a genetic locus (Gct1) fundamental for spontaneous ovarian granulosa cell tumorigenesis in a mouse model Cancer Res 65 1259 1264 10.1158/0008-5472.CAN-04-2992 15735010 (Pubitemid 40270151)
58. V Bliskovsky ES Ramsay J Scott W DuBois W Shi S Zhang X Qian DR Lowy BA Mock 2003 Frap, FKBP12 rapamycin-associated protein, is a candidate gene for the plasmacytoma resistance locus Pctr2 and can act as a tumor suppressor gene Proc Natl Acad Sci USA 100 14982 14987 10.1073/pnas.2431627100 14634209 (Pubitemid 37518003)
59. T van Wezel CA Ruivenkamp AP Stassen CJ Moen P Demant 1999 Four new colon cancer susceptibility loci, Scc6 to Scc9 in the mouse Cancer Res 59 4216 4218 10485458
60. S Bernichtein E Petretto S Jamieson A Goel TJ Aitman JM Mangion IT Huhtaniemi 2008 Adrenal gland tumorigenesis after gonadectomy in mice is a complex genetic trait driven by epistatic loci Endocrinology 149 651 661 10.1210/en.2007-0925 18006632 (Pubitemid 351159319)
61. MS Ko JR Kitchen X Wang TA Threat X Wang A Hasegawa T Sun MJ Grahovac GJ Kargul MK Lim Y Cui Y Sano T Tanaka Y Liang S Mason PD Paonessa AD Sauls GE DePalma R Sharara LB Rowe J Eppig C Morrell H Doi 2000 Large-scale cDNA analysis reveals phased gene expression patterns during preimplantation mouse development Development 127 1737 1749 10725249
62. ME Durkin MR Avner CG Huh BZ Yuan SS Thorgeirsson NC Popescu 2005 DLC-1, a Rho GTPase-activating protein with tumor suppressor function, is essential for embryonic development. FEBS Lett 579 1191 1196 10.1016/j.febslet.2004.12.090 15710412 (Pubitemid 40248686)
63. D Wang WJ Lemon M You 2002 Linkage disequilibrium mapping of novel lung tumor susceptibility quantitative trait loci in mice Oncogene 21 6858 6865 10.1038/sj.onc.1205886 12360413 (Pubitemid 35221929)